Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
LTGO
LATIGO BIOTHERAPEUTICS INC
$18.103.55%-13.06%-17.80%N/AN/AN/AN/AN/AN/A$25.93$16.1930.20%11.80%0.69955,000264.50%
RCUS
ARCUS BIOSCIENCES INC
$25.652.56%-4.54%-12.40%-17.47%24.21%92.57%42.90%-25.67%N/A$31.74$12.9019.17%98.91%1.561,252,0000.24%
ANIX
ANIXA BIOSCIENCES INC
$2.852.15%2.15%-14.93%0.00%14.00%-16.42%-12.84%-40.00%-12.84%$5.46$2.3247.80%22.84%1.01183,000-40.20%
AVIR
ATEA PHARMACEUTICALS INC
$5.18-0.38%-8.16%-3.18%12.36%1.97%77.40%72.67%-83.88%N/A$6.45$2.7819.69%86.33%1.00298,00025.21%
NRIX
NURIX THERAPEUTICS INC
$23.680.02%-7.77%-8.17%-0.73%61.38%155.12%201.21%-19.69%N/A$28.23$8.8516.14%167.51%1.552,275,00013.30%
BOLD
BOUNDLESS BIO INC
$2.56-1.92%-11.11%-8.90%4.49%135.94%113.33%N/AN/AN/A$3.16$0.9619.09%166.39%0.9952,000-63.38%
IRON
DISC MEDICINE INC
$65.871.46%-3.81%-16.25%-11.58%8.37%1.25%40.21%59.11%N/A$99.50$40.0033.80%64.68%0.91784,00063.33%
NXTC
NEXTCURE INC
$4.85-4.63%-6.47%-24.18%176.86%-51.06%-16.32%-68.70%-94.09%N/A$15.74$1.5569.22%212.58%0.8355,400-12.06%
IMTX
IMMATICS NV
$8.560.71%-3.49%-10.18%-10.46%-7.96%8.22%-26.08%-32.86%N/A$12.41$8.0631.02%6.20%1.04644,000-56.13%
MNPR
MONOPAR THERAPEUTICS
$80.00-4.44%-17.21%-28.53%-15.40%50.12%5.40%2,481.48%230.58%N/A$124.42$50.0735.70%59.78%0.83162,000-39.55%
OBX
OBSIDIAN THERAPEUTICS INC
$14.589.05%-14.24%-16.73%N/AN/AN/AN/AN/AN/A$49.97$12.1670.82%19.90%6.83379,000-58.49%
DNLI
DENALI THERAPEUTICS INC
$20.81-0.81%-3.66%-12.42%-19.62%15.10%43.32%0.87%-57.89%N/A$27.30$13.7523.77%51.35%1.601,390,000-45.70%
VANI
VIVANI MEDICAL INC
$1.23-1.60%-3.15%-11.51%1.65%31.13%-12.14%20.59%-86.82%-98.43%$1.92$0.9235.94%33.26%0.8783,000-22.43%
PEPG
PEPGEN INC
$2.34-9.65%-21.48%-21.74%31.46%-44.68%-49.57%-53.94%N/AN/A$7.80$1.3170.00%78.63%1.072,347,000217.16%
TRDA
ENTRADA THERAPEUTICS INC
$6.260.64%-6.71%-11.21%-18.81%-46.81%7.19%-60.38%N/AN/A$16.45$5.5561.95%12.79%1.12269,000-39.28%
BRVE
BRAVEHEART BIO INC
$22.346.03%-5.38%-12.39%N/AN/AN/AN/AN/AN/A$32.00$20.0130.19%11.64%-1.26719,00084.83%
BIVI
BIOVIE INC
$1.540.00%-5.52%-32.46%-23.38%14.07%-19.37%-99.55%-99.77%N/A$3.79$0.8259.37%87.80%1.53145,000-20.77%
SPTX
SEAPORT THERAPEUTICS INC
$18.69-4.84%-16.53%-21.07%-17.01%N/AN/AN/AN/AN/A$28.38$14.8534.14%25.86%1.10278,000-2.11%
IPSC
CENTURY THERAPEUTICS INC
$1.65-1.20%-12.70%-19.51%-31.54%-18.72%230.00%-17.50%-92.99%N/A$3.04$0.4445.72%279.31%1.37354,000-13.45%
IMUX
IMMUNIC INC
$8.91-6.31%-17.80%-43.61%-42.18%-13.50%-4.69%-39.39%-90.20%-99.63%$17.43$5.0648.88%76.02%1.18435,000-34.09%
CLYM
CLIMB BIO INC
$11.50-2.04%-19.07%-16.24%-13.92%75.84%477.89%337.26%-33.26%N/A$18.33$1.5437.26%646.75%0.821,071,00032.06%
OCGN
OCUGEN INC
$1.095.83%4.81%-18.05%-34.73%-37.71%-24.83%172.50%-84.02%-99.44%$2.73$0.9760.00%12.37%2.047,545,00055.25%
GHRS
GH RESEARCH PLC
$24.675.34%-11.45%-8.56%-13.41%89.33%69.79%145.47%12.39%N/A$31.44$12.0421.53%104.90%1.051,132,00085.57%
PLRX
PLIANT THERAPEUTICS INC
$1.080.00%-5.26%-1.82%-6.09%-8.09%-27.52%-93.77%-93.45%N/A$1.95$1.0244.62%5.88%0.99214,000-38.68%
ICU
SEASTAR MEDICAL HOLDING CORP
$3.564.71%0.85%13.74%0.28%-1.66%-40.67%-94.61%-99.86%N/A$7.35$2.0751.56%71.98%0.18135,0001,150.00%
VSTM
VERASTEM INC
$7.921.93%-5.38%9.70%107.33%63.30%-8.33%-2.58%-78.29%-50.00%$10.82$3.4326.80%130.90%1.552,677,000112.29%
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$13.70-5.26%-4.73%-7.18%100.88%98.55%-27.05%-46.38%-70.70%-22.03%$24.17$5.5043.32%149.09%1.95432,000-47.64%
LYEL
LYELL IMMUNOPHARMA INC
$9.63-1.13%-13.63%-32.75%-24.47%-50.08%-35.67%-67.24%-96.69%N/A$45.00$9.4578.60%1.96%1.61141,0009.30%
GNPX
GENPREX INC
$2.851.42%-19.49%-23.18%-74.35%-92.68%-98.45%-99.98%-100.00%N/A$1.21k$2.7099.76%5.56%1.17103,000-81.87%
ZLAB
ZAI LAB LTD
$25.930.93%-1.82%1.85%40.85%45.27%-21.26%6.66%-75.76%N/A$34.72$15.9625.32%62.47%1.18549,000-37.97%
NUVB
NUVATION BIO INC
$5.620.36%-7.87%-15.62%0.18%38.77%74.53%319.40%-41.88%N/A$9.75$3.3642.36%67.26%1.383,067,000-33.21%
VBIO
VALION BIO INC
$2.834.81%13.65%-20.73%-79.42%-86.68%-96.12%-99.62%N/AN/A$78.75$2.0596.41%38.05%1.00366,00071.83%
NAMS
NEWAMSTERDAM PHARMA CO NV
$23.810.98%2.10%-6.04%-29.70%-18.82%-13.48%157.41%142.46%N/A$42.21$21.0243.58%13.27%0.541,069,000-48.03%
DMRA
DAMORA THERAPEUTICS INC
$20.66-0.43%-7.81%-26.69%-14.66%-14.87%443.68%14.85%-77.17%N/A$38.33$3.5046.09%490.29%1.43376,000-26.99%
PALI
PALISADE BIO INC
$1.45-3.33%-14.20%-25.64%-34.98%-18.54%57.27%-83.39%-99.93%-100.00%$2.86$0.9649.21%50.57%1.202,161,000-75.12%
BLSM
BLOSSOMHILL THERAPEUTICS INC
$21.370.14%-15.37%16.78%N/AN/AN/AN/AN/AN/A$27.99$15.2523.65%40.13%0.90228,00056.16%
TRAX
FIRST TRACKS BIOTHERAPEUTICS INC
$35.98-1.81%-12.31%-14.01%111.52%N/AN/AN/AN/AN/A$49.91$14.8827.91%141.80%2.59646,000-4.15%
EWTX
EDGEWISE THERAPEUTICS INC
$39.19-1.51%-11.95%-6.18%-4.23%29.43%148.83%583.94%130.53%N/A$48.51$14.2519.21%175.02%1.41947,000-68.26%
GYRE
GYRE THERAPEUTICS INC
$7.32-2.27%-2.27%11.42%13.49%7.02%-2.40%1.17%-88.16%-97.31%$9.42$5.4422.29%34.56%1.32115,000-16.06%
VTVT
VTV THERAPEUTICS INC
$30.00-1.70%-3.54%-6.25%-17.29%-18.26%30.78%56.90%-51.92%-89.51%$44.00$19.5031.82%53.85%0.8785,000-24.11%
ACRV
ACRIVON THERAPEUTICS INC
$2.080.97%-3.26%-0.48%16.85%61.24%14.29%-78.24%N/AN/A$3.56$1.2741.57%63.78%1.60132,000-42.86%
CYTK
CYTOKINETICS INC
$65.64-0.79%-2.89%-7.43%-24.78%4.24%21.80%122.81%95.42%633.41%$88.31$53.6225.67%22.42%0.992,401,000-5.88%
NNVC
NANOVIRICIDES INC
$1.30-13.33%-15.03%4.00%-5.11%49.43%-8.45%-2.99%-71.43%-96.11%$2.23$0.8541.70%52.94%1.01955,00050.87%
CBUS
CIBUS INC
$1.555.44%-2.52%-4.32%8.39%-14.84%18.32%-91.49%-99.09%N/A$4.19$1.0963.02%42.20%1.47270,000162.14%
SVRA
SAVARA INC
$5.080.20%-4.15%-5.75%-15.75%0.59%44.32%34.39%300.00%N/A$7.01$3.3427.48%52.10%0.892,034,000-53.48%
SGP
SPYGLASS PHARMA INC
$25.44-2.08%-11.33%-2.53%17.51%8.86%N/AN/AN/AN/A$32.44$17.0621.58%49.12%1.5168,000-43.33%
PLRZ
POLYRIZON LTD
$10.491.25%-1.59%-27.71%-17.73%-11.70%54.72%N/AN/AN/A$18.20$2.8842.36%264.24%0.418,70093.33%
ENTA
ENANTA PHARMACEUTICALS INC
$12.640.20%1.77%-5.18%-12.89%3.78%-16.62%13.16%-77.47%-50.82%$17.15$9.9126.30%27.55%0.99323,000-7.45%
FTH
FAETH THERAPEUTICS INC
$28.071.08%-15.96%-14.34%20.89%11.70%193.93%75.44%-87.05%N/A$42.14$7.4533.39%276.78%1.01251,00028.06%
BMEA
BIOMEA FUSION INC
$1.26-2.33%-25.88%-25.00%-9.35%-4.55%-38.83%-90.84%-88.45%N/A$2.99$0.8757.86%44.50%1.121,556,0006.79%
AVLN
AVALYN PHARMA INC
$27.10-4.31%-16.49%-21.97%-12.58%N/AN/AN/AN/AN/A$40.17$24.1532.54%12.22%0.14422,000104.85%
CGTX
COGNITION THERAPEUTICS INC
$0.951.71%-2.75%-7.38%-12.48%60.34%-33.29%-33.75%N/AN/A$2.05$0.5553.46%73.45%1.38525,000161.19%
PDSB
PDS BIOTECHNOLOGY CORP
$0.74-3.00%-18.35%247.20%-17.35%38.62%-26.44%-85.29%-95.00%-99.64%$1.55$0.2052.06%281.03%1.952,658,000-34.24%
CRBU
CARIBOU BIOSCIENCES INC
$1.240.81%-7.46%-19.48%-29.94%-27.91%-46.09%-74.06%-94.79%N/A$3.54$1.2264.92%1.64%1.86637,000-22.22%
DMAC
DIAMEDICA THERAPEUTICS INC
$8.20-1.44%5.40%29.13%13.57%23.49%18.67%217.83%102.97%N/A$10.42$5.2521.30%56.34%0.90231,000-36.36%
ODTX
ODYSSEY THERAPEUTICS INC
$22.444.52%-3.86%-8.48%18.79%N/AN/AN/AN/AN/A$29.05$15.1022.75%48.61%1.49201,000-5.63%
GLUE
MONTE ROSA THERAPEUTICS INC
$11.740.26%-6.83%-15.78%-50.88%-24.40%60.60%145.09%-48.17%N/A$25.77$7.2454.44%62.27%1.61545,000-29.50%
IONS
IONIS PHARMACEUTICALS INC
$45.890.70%0.31%-23.97%-43.13%-36.72%-28.46%1.17%36.66%29.01%$86.74$43.0147.09%6.70%0.783,635,000-2.86%
GLSI
GREENWICH LIFESCIENCES INC
$18.38-1.13%-5.65%22.94%-20.95%-14.47%80.91%107.92%-53.02%N/A$34.10$7.7846.10%136.25%1.3966,000-20.48%
KLRS
KALARIS THERAPEUTICS INC
$2.901.93%-10.49%-28.22%-31.20%-45.28%-54.33%-94.14%-99.49%N/A$11.88$2.8175.59%3.20%1.4352,000-44.09%
TTRX
TURN THERAPEUTICS INC
$13.412.84%-12.30%39.69%94.07%316.46%N/AN/AN/AN/A$26.50$2.5749.40%421.79%1.3679,5003.25%
ELAB
PMGC HOLDINGS INC
$3.67-23.22%-13.85%-29.29%-69.67%-89.69%-99.72%N/AN/AN/A$2.67k$3.4099.86%7.94%1.79199,000-21.34%
PTHS
PELTHOS THERAPEUTICS INC
$20.92-1.55%-9.98%-13.12%-24.07%-0.38%-30.27%N/AN/AN/A$37.42$18.1944.09%15.01%1.029,400-21.67%
DTIL
PRECISION BIOSCIENCES INC
$6.18-0.96%-14.05%-19.11%-21.97%14.02%21.41%-39.64%-98.22%N/A$9.62$3.5335.76%75.07%1.26154,000-30.94%
FLNA
FILANA THERAPEUTICS INC
$0.938.82%-10.19%3.01%-24.18%-42.90%-70.54%-94.44%-98.51%-86.92%$4.98$0.6781.43%38.06%1.211,204,000-41.38%
MNKD
MANNKIND CORP
$3.34-0.30%-4.30%-16.71%-21.23%40.93%-38.03%-19.13%-25.45%11.67%$6.51$2.2348.69%49.78%1.122,368,00013.96%
GANX
GAIN THERAPEUTICS INC
$1.68-5.08%-13.85%-6.67%-15.15%-6.67%-7.18%-48.78%-78.04%N/A$4.34$1.5361.29%9.80%1.151,290,000135.40%
MIRM
MIRUM PHARMACEUTICALS INC
$87.54-0.48%-4.21%-10.72%-28.83%-0.41%20.16%177.03%368.88%N/A$130.00$63.2332.66%38.44%0.75667,000-46.08%
PMN
PROMIS NEUROSCIENCES INC
$10.64-0.14%-21.69%-18.63%-1.07%-17.43%-3.32%-78.52%N/AN/A$27.40$6.2761.19%69.62%0.5017,000-32.00%
CLNN
CLENE INC
$4.100.99%-6.39%-4.21%-35.28%-14.94%-31.55%-58.66%-97.01%N/A$13.50$3.2569.63%26.15%0.8370,400-23.48%
AVTX
AVALO THERAPEUTICS INC
$15.583.32%-5.63%-19.44%-19.23%11.84%19.66%-46.22%-99.76%-99.88%$24.27$12.4135.81%25.55%0.851,331,00077.47%
OTLK
OUTLOOK THERAPEUTICS INC
$0.630.81%-10.06%-1.11%-62.96%211.44%-40.94%-85.84%-98.53%-99.91%$2.54$0.1675.33%288.82%1.004,563,000-25.17%
ELVN
ENLIVEN THERAPEUTICS INC
$46.511.09%-3.49%-19.66%-8.53%27.11%129.11%240.48%184.99%N/A$62.32$14.7925.37%214.58%1.111,256,000-2.26%
HURA
TUHURA BIOSCIENCES INC
$2.07-0.96%-2.82%-2.82%-9.61%19.65%-16.19%-98.54%-99.86%-100.00%$3.41$0.4139.30%404.88%1.04231,000-38.40%
BDTX
BLACK DIAMOND THERAPEUTICS INC
$1.872.19%-5.56%-10.95%6.86%-7.88%-49.87%-34.84%-79.36%N/A$4.94$1.6062.15%16.88%1.66439,000-32.25%
BSEM
BIOSTEM TECHNOLOGIES INC
$3.83-5.43%-3.77%4.08%N/AN/AN/AN/AN/AN/A$5.44$2.2529.60%70.15%-0.4950,000-72.53%
DBVT
DBV TECHNOLOGIES SA
$11.55-0.77%-8.55%-16.43%-27.81%-40.95%26.33%-15.07%-75.63%-96.81%$26.19$9.1955.89%25.68%0.48199,000-72.09%
COYA
COYA THERAPEUTICS INC
$5.031.00%-5.09%10.31%-17.13%33.07%-11.13%30.99%N/AN/A$7.75$3.7135.10%35.58%1.0275,500-37.08%
EIKN
EIKON THERAPEUTICS INC
$7.910.00%-11.92%-24.38%-37.91%-18.29%N/AN/AN/AN/A$17.40$7.5554.54%4.84%2.20335,000-22.99%
QSI
QUANTUM-SI INC
$0.9620.50%22.04%25.07%7.76%29.81%-31.08%-42.29%-88.61%N/A$3.10$0.6969.10%38.84%2.3022,830,0001,356.92%
ZBIO
ZENAS BIOPHARMA INC
$26.76-2.87%-19.03%-17.20%4.74%46.83%30.09%N/AN/AN/A$44.60$13.5040.00%98.22%1.28441,000-28.29%
AARD
AARDVARK THERAPEUTICS INC
$5.351.52%-6.96%-12.30%3.28%46.98%-60.89%N/AN/AN/A$17.94$3.3570.18%59.70%2.0040,000-33.99%
IDYA
IDEAYA BIOSCIENCES INC
$37.86-0.94%-4.66%-5.59%3.58%20.38%39.24%40.33%52.11%N/A$42.68$26.0511.29%45.34%1.09815,000-22.68%
PMVP
PMV PHARMACEUTICALS INC
$1.435.15%-5.30%18.18%10.85%17.21%-1.38%-76.71%-95.21%N/A$1.88$1.0223.94%40.20%1.16551,00061.11%
TRVI
TREVI THERAPEUTICS INC
$14.420.14%-5.38%-13.13%-22.60%28.87%61.12%561.47%960.29%N/A$20.15$8.9928.44%60.40%0.762,045,00026.70%
ATTO
ATTOVIA THERAPEUTICS INC
$18.162.89%-12.82%-15.14%N/AN/AN/AN/AN/AN/A$28.00$16.1535.14%12.45%1.76887,000120.10%
AKTX
AKARI THERAPEUTICS PLC
$9.72-0.92%-3.28%-6.81%0.31%100.83%-76.20%-93.85%-99.27%-99.85%$44.20$3.0278.01%222.39%0.5650,700-38.17%
RAPP
RAPPORT THERAPEUTICS INC
$33.02-1.26%-20.38%-32.16%-18.25%19.25%18.06%N/AN/AN/A$52.93$23.7537.62%39.03%1.34626,00013.41%
CLDI
CALIDI BIOTHERAPEUTICS INC
$1.080.93%-2.88%-19.40%-58.11%-71.77%-95.62%-99.98%-99.99%N/A$27.84$1.0396.12%4.85%0.6843,000-72.08%
LGVN
LONGEVERON INC
$2.723.42%0.00%-60.58%-61.68%-70.77%-64.68%-98.84%-99.24%N/A$12.30$2.3077.89%18.26%1.1655,000-46.08%
AKTS
AKTIS ONCOLOGY INC
$19.691.76%-10.95%-24.01%-34.61%19.04%N/AN/AN/AN/A$34.19$14.7242.41%33.76%1.56195,000-12.56%
DFTX
DEFINIUM THERAPEUTICS INC
$38.21-0.52%-5.23%-3.80%-17.92%118.34%217.36%1,120.77%8.40%N/A$49.70$10.4723.12%265.12%1.571,967,000-34.30%
KRRO
KORRO BIO INC
$9.560.53%-7.54%-23.46%-27.55%-7.00%-77.66%-48.32%-97.27%N/A$55.89$5.2082.89%83.70%1.3993,000-29.55%
LABT
LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC
$0.99-13.91%-50.25%-60.40%-71.55%N/AN/AN/AN/AN/A$98.20$0.9298.99%7.26%-1.061,231,000-96.45%
ERAS
ERASCA INC
$14.210.57%-8.62%-20.53%-22.31%-4.89%573.46%621.32%-28.38%N/A$24.28$2.1041.47%576.67%1.423,203,000-10.95%
ANRO
ALTO NEUROSCIENCE INC
$26.58-0.30%-13.65%-24.87%-5.31%33.03%562.84%N/AN/AN/A$37.48$4.0029.08%564.50%1.23763,00029.98%
EQ
EQUILLIUM INC
$1.62-3.57%-16.06%-28.63%-47.40%-7.43%10.96%118.92%-73.66%N/A$3.54$0.7654.24%114.29%0.73316,00030.58%
OBIO
ORCHESTRA BIOMED HOLDINGS INC
$6.083.23%-2.25%20.63%28.00%49.39%147.15%-30.28%-38.21%N/A$6.48$2.426.17%151.45%0.94237,00033.90%
CRVO
CERVOMED INC
$2.887.87%13.83%9.51%-8.57%-20.44%-64.36%-37.66%-92.30%-99.96%$10.00$2.1571.20%34.27%0.98456,000166.67%
MBX
MBX BIOSCIENCES INC
$57.750.36%-6.82%-6.25%7.24%114.52%221.91%N/AN/AN/A$72.64$12.9420.50%346.29%1.43357,000-18.86%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)


Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)


Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)


Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)


Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.